Moderna Q1 2024 Earnings Results

Moderna presented first quarter 2024 financial results and business update on May 2, 2024, including RSV vaccine commercialization plans, 2024 financial guidance, and pipeline milestones. The earnings presentation outlined anticipated product sales, competitive positioning, and clinical development progress for multiple mRNA programs.